JPWO2022223784A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022223784A5 JPWO2022223784A5 JP2023564409A JP2023564409A JPWO2022223784A5 JP WO2022223784 A5 JPWO2022223784 A5 JP WO2022223784A5 JP 2023564409 A JP2023564409 A JP 2023564409A JP 2023564409 A JP2023564409 A JP 2023564409A JP WO2022223784 A5 JPWO2022223784 A5 JP WO2022223784A5
- Authority
- JP
- Japan
- Prior art keywords
- frα
- composition
- subject
- less
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/060749 WO2021214329A1 (en) | 2020-04-24 | 2021-04-23 | Composition comprising an ige antibody |
| EPPCT/EP2021/060749 | 2021-04-23 | ||
| GBGB2109550.0A GB202109550D0 (en) | 2021-07-01 | 2021-07-01 | Composition |
| GB2109550.0 | 2021-07-01 | ||
| PCT/EP2022/060693 WO2022223784A1 (en) | 2021-04-23 | 2022-04-22 | Composition comprising an ige antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514935A JP2024514935A (ja) | 2024-04-03 |
| JP2024514935A5 JP2024514935A5 (https=) | 2025-04-18 |
| JPWO2022223784A5 true JPWO2022223784A5 (https=) | 2025-04-18 |
Family
ID=81750377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564409A Pending JP2024514935A (ja) | 2021-04-23 | 2022-04-22 | ＩｇＥ抗体を含む組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240190955A1 (https=) |
| EP (1) | EP4326770A1 (https=) |
| JP (1) | JP2024514935A (https=) |
| KR (1) | KR20240001136A (https=) |
| AU (1) | AU2022263376A1 (https=) |
| BR (1) | BR112023021873A2 (https=) |
| CA (1) | CA3215850A1 (https=) |
| MX (1) | MX2023012557A (https=) |
| WO (1) | WO2022223784A1 (https=) |
| ZA (1) | ZA202309456B (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| CN103037900B (zh) | 2010-02-24 | 2016-04-06 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| CA2848842C (en) | 2011-10-04 | 2020-09-29 | King's College London | Ige anti -hmw-maa antibody |
| RU2019141270A (ru) | 2017-05-16 | 2021-06-16 | Иммуноджен, Инк. | Комбинации анти-folr1 иммуноконъюгатов и анти-pd-1 антител |
| GB202006093D0 (en) * | 2020-04-24 | 2020-06-10 | King S College London | Composition |
-
2022
- 2022-04-22 AU AU2022263376A patent/AU2022263376A1/en active Pending
- 2022-04-22 EP EP22724722.8A patent/EP4326770A1/en active Pending
- 2022-04-22 KR KR1020237035816A patent/KR20240001136A/ko active Pending
- 2022-04-22 CA CA3215850A patent/CA3215850A1/en active Pending
- 2022-04-22 MX MX2023012557A patent/MX2023012557A/es unknown
- 2022-04-22 WO PCT/EP2022/060693 patent/WO2022223784A1/en not_active Ceased
- 2022-04-22 US US18/287,623 patent/US20240190955A1/en active Pending
- 2022-04-22 JP JP2023564409A patent/JP2024514935A/ja active Pending
- 2022-04-22 BR BR112023021873A patent/BR112023021873A2/pt unknown
-
2023
- 2023-10-10 ZA ZA2023/09456A patent/ZA202309456B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025036633A (ja) | 担体および抗体からなる組成物およびその製造および使用方法 | |
| ES2731601T3 (es) | Composiciones de dosificación oral de liberación retardada que contienen CDDO-Me amorfo | |
| CN118203658A (zh) | 一种重组抗Claudin18.2全人源单克隆抗体注射液制剂及制备方法 | |
| FI3576788T3 (fi) | Matalan ph-arvon omaava farmaseuttinen koostumus, joka käsittää t-soluihin sitoutuvia vasta-ainekonstrukteja | |
| JPH03188021A (ja) | レトロウイルスを撲滅するための医薬品およびその製造法 | |
| US12065494B2 (en) | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent | |
| CN110354073B (zh) | 一种免疫抑制剂单克隆抗体的液体制剂 | |
| WO2021027704A1 (zh) | 多肽或其衍生物的应用 | |
| Cheng et al. | Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors | |
| US20190241660A1 (en) | Immune-stimulating peptides and checkpoint inhibitors, and uses thereof for treating cancer | |
| CN111375057A (zh) | 一种包含抗Her2单克隆抗体的药物配制剂 | |
| KR20250010625A (ko) | 항 Nectin-4 항체-약물 접합체를 함유하는 약학적 조성물 및 이의 용도 | |
| RU2678772C2 (ru) | Композиция кабазитаксела | |
| JPWO2022223784A5 (https=) | ||
| JPH0585942A (ja) | インターフエロン−ヒアルロン酸及び／又はその塩の結合体 | |
| CN107334728A (zh) | 一种稳定抗人pd-1的单克隆抗体的溶液制剂 | |
| CN113082203B (zh) | 一种免疫抑制剂单克隆抗体的液体制剂 | |
| EP3675841B1 (en) | A novel quinochalcone compound and uses thereof for treating cancer or inflammation | |
| CN119735597B (zh) | 靶向pgk1的小分子化合物及其应用 | |
| US20240398843A1 (en) | Glycyrrhizin-branched polyethylene glycol conjugate for treating cancer | |
| CN100396289C (zh) | 灯盏花乙素注射制剂及其制备方法 | |
| CN111728960B (zh) | 富马酸比索洛尔联合多西他赛在制备抗肿瘤药物中的应用 | |
| WO2020040296A1 (ja) | Ｐｅｇ化ホウ素クラスター化合物、およびｐｅｇ化ホウ素クラスター化合物を含む抗腫瘍剤、およびｐｅｇ化ホウ素クラスターを含む増感剤 | |
| CN100336557C (zh) | 一种生长抑素的水溶液制剂、其制备方法及应用 | |
| US20250049869A1 (en) | Use of auricularia auricula total polysaccharide or monomeric polysaccharide in preparation of pd-l1 inhibitor |